Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      • Home
      • Farhat Nasim

      Articles By : Farhat Nasim

      Sonoco acquires healthcare packaging, medical device thermoformer-TEQ for USD 187 million

      Sonoco acquires healthcare packaging, medical device thermoformer-TEQ for USD 187 million

      Farhat Nasim4 Jan 2020 9:15 AM IST
      Sonoco funded the TEQ transaction using short-term credit facilities and it is expected to be accretive to Sonoco’s 2020 earnings. New Delhi: Sonoco,...
      Karnataka: Around 2000 Govt Pharmacists launch protest, threaten indefinite strike

      Karnataka: Around 2000 Govt Pharmacists launch protest, threaten indefinite strike

      Farhat Nasim3 Jan 2020 5:19 PM IST
      The protest in Karnataka is likely to take a major turn as the association is of the view that if the government fails to fulfil their demands,...
      11 Drugs Controller Officers appointed in Punjab; Details

      11 Drugs Controller Officers appointed in Punjab; Details

      Farhat Nasim2 Jan 2020 3:46 PM IST
      "Now with the recruitment of these 11 drugs controller officers, the FDA would expedite the action against the chemists who are indulging in unethical...
      GSK divests rabies, tick-borne encephalitis vaccines Rabipur, Encepur to Bavarian Nordic

      GSK divests rabies, tick-borne encephalitis vaccines Rabipur, Encepur to Bavarian Nordic

      Farhat Nasim2 Jan 2020 2:55 PM IST
      The decision to divest these brands supports GSK Plc’s strategic intent to increase focus and reinvest in growth assets, innovation and a simplified...
      NPPA fixes retail price of 7 drug formulations; Details

      NPPA fixes retail price of 7 drug formulations; Details

      Farhat Nasim1 Jan 2020 10:30 AM IST
      New Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
      Alkem Labs to acquire Dronabinol assets for Rs 71 crore from AbbVie

      Alkem Labs to acquire Dronabinol assets for Rs 71 crore from AbbVie

      Farhat Nasim1 Jan 2020 10:09 AM IST
      The assets related to Dronabinol include domain names and trademarks pertaining to 'Marinol', New Drug Application (NDA) registration with US Food and...
      Indoco Remedies Febuxostat Tablets get USFDA nod to treat gout by Hyperuricemia

      Indoco Remedies Febuxostat Tablets get USFDA nod to treat gout by Hyperuricemia

      Farhat Nasim1 Jan 2020 9:45 AM IST
      Mumbai: Drugmaker, Indoco Remedies informed that the company has received final approval of its ANDA for Febuxostat Tablets 40 mg and 80 mg for the...
      Sanofi, Pfizer, GSK to hike US prices on over 200 drugs: Report

      Sanofi, Pfizer, GSK to hike US prices on over 200 drugs: Report

      Farhat Nasim1 Jan 2020 9:36 AM IST
      Nearly all of the price increases will be below 10%, and around half of them are in the range of 4 to 6%, said 3 Axis co-founder Eric Pachman. The...
      Eli Lilly gets favourable US court ruling in Alimta vitamin regimen patent lawsuit

      Eli Lilly gets favourable US court ruling in Alimta vitamin regimen patent lawsuit

      Farhat Nasim1 Jan 2020 9:35 AM IST
      "We are pleased with today's District Court ruling finding the Alimta vitamin regimen patent would be infringed by the competitor's proposed...
      Janssen Pharma completes acquisition of bermekimab from XBiotech for USD 750 million

      Janssen Pharma completes acquisition of bermekimab from XBiotech for USD 750 million

      Farhat Nasim1 Jan 2020 9:30 AM IST
      New Delhi: The Janssen Pharmaceutical Companies of Johnson & Johnson announced recently the completion of the acquisition of all rights to the...
      Similarity of Trademarks: Delhi HC refrains manufacture, sale of Rifaget, Zoe-Fer against Sun Pharma trademark Rifagut, Zofer

      Similarity of Trademarks: Delhi HC refrains manufacture, sale of Rifaget, Zoe-Fer against Sun Pharma trademark Rifagut, Zofer

      Farhat Nasim31 Dec 2019 4:51 PM IST
      New Delhi: The Delhi High Court has ordered a permanent injunction stopping the sale of drug/supplement for iron deficiency in lactating and expecting...
      CDSCO declares 37 drug samples including Ibuprofen, Vitamin B-Complex as Not of Standard Quality

      CDSCO declares 37 drug samples including Ibuprofen, Vitamin B-Complex as Not of Standard Quality

      Farhat Nasim30 Dec 2019 5:03 PM IST
      New Delhi: The nodal drug regulatory body, the Central Drugs Standard Control Organization (CDSCO) has declared batches of 37 drugs including...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok